Cargando…

The first second-generation adenosine drug enters the US market

Detalles Bibliográficos
Autores principales: Pelleg, Amir, Belardinelli, Luiz
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583212/
https://www.ncbi.nlm.nih.gov/pubmed/18566916
http://dx.doi.org/10.1007/s11302-008-9114-2
_version_ 1782160737652703232
author Pelleg, Amir
Belardinelli, Luiz
author_facet Pelleg, Amir
Belardinelli, Luiz
author_sort Pelleg, Amir
collection PubMed
description
format Text
id pubmed-2583212
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-25832122009-01-26 The first second-generation adenosine drug enters the US market Pelleg, Amir Belardinelli, Luiz Purinergic Signal Article Springer Netherlands 2008-06-20 2008-12 /pmc/articles/PMC2583212/ /pubmed/18566916 http://dx.doi.org/10.1007/s11302-008-9114-2 Text en © Springer Science+Business Media B.V. 2008
spellingShingle Article
Pelleg, Amir
Belardinelli, Luiz
The first second-generation adenosine drug enters the US market
title The first second-generation adenosine drug enters the US market
title_full The first second-generation adenosine drug enters the US market
title_fullStr The first second-generation adenosine drug enters the US market
title_full_unstemmed The first second-generation adenosine drug enters the US market
title_short The first second-generation adenosine drug enters the US market
title_sort first second-generation adenosine drug enters the us market
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583212/
https://www.ncbi.nlm.nih.gov/pubmed/18566916
http://dx.doi.org/10.1007/s11302-008-9114-2
work_keys_str_mv AT pellegamir thefirstsecondgenerationadenosinedrugenterstheusmarket
AT belardinelliluiz thefirstsecondgenerationadenosinedrugenterstheusmarket
AT pellegamir firstsecondgenerationadenosinedrugenterstheusmarket
AT belardinelliluiz firstsecondgenerationadenosinedrugenterstheusmarket